Partnership

A Texas startup just hit a critical nuclear milestone, racing to solve AI's energy crisis. But can its ambitious plan navigate regulatory reality?

Shilpa Medicare and Orion Corp. partner on a nivolumab biosimilar, challenging Big Pharma and promising affordable access to a vital cancer immunotherapy.

A new video series from Anthem and USA TODAY aims to educate consumers. But is it a public service or a sophisticated marketing strategy to cut costs?

As global regulations tighten and AI-generated code floods development, a critical accuracy gap in software security is widening. Enter binary-level analysis.

A new $200K award isn't just a grant; it's a strategic bet on systems engineering to fix a diagnostic pathway where 70% of lung cancer cases are found too late.

A new licensing deal for a space camera isn't just a product launch; it’s a strategic signal of America’s push for a sovereign tech supply chain.

Beyond produce, a new partnership at the Obama Center is growing self-determination. Urban Growers Collective is reframing gardening as civic action.

A massive acquisition, key exploration wins, and a state partnership have transformed Parex. We dissect the strategy behind its bold H2 2026 production goals.

VERAXA Biotech is betting its future on its proprietary BiTAC technology, a strategic pivot that sharpens its focus amid a volatile market for cancer therapies.

A new collaboration between beauty brand MONCLOS and lifestyle icon BALANSA isn't just a product launch; it's a signal of K-beauty's strategic pivot.

A South Korean biotech's diabetes drug finds new purpose in fighting FSHD, backed by a foundation's innovative funding model that could reshape rare disease R&D.

The Hong Kong Jockey Club is fusing horse racing with the World Cup. We uncover the quiet operational innovation behind this global entertainment spectacle.

Australian biotech Immuron hires a top dealmaker to land a partner for its novel C. diff therapy. The goal: secure funding and unlock a potential $400M market.

With its AUM soaring to $600B, Mubadala Capital is making a bold play in private credit, signaling a new era for sovereign-backed asset managers.

Just two years old, UK fertility startup Avenues is expanding globally with an AI-driven model promising unprecedented growth. But can tech truly scale compassion?

Ryan Specialty’s new consortium with six Lloyd’s syndicates isn't just a capacity play. It’s a tech-driven model for the future of delegated underwriting.

Emirates NBD's new partnership with Techstars isn't just another accelerator; it's a strategic move to directly integrate AI startups into its core operations.

A new partnership promises to give our aging power grids a high-resolution nervous system, tackling the immense pressures of AI, EVs, and renewables.

With record sales and strategic deals, this French innovator is proving that green cement isn't just possible, it's profitable and scaling fast.

A social gaming app's small donation to a youth football project signals a larger shift: how tech is bridging virtual connection with real-world impact.